InvestorsHub Logo

DR5

Followers 10
Posts 1118
Boards Moderated 0
Alias Born 01/05/2018

DR5

Re: dogooder post# 1536

Tuesday, 09/04/2018 11:03:48 AM

Tuesday, September 04, 2018 11:03:48 AM

Post# of 13987
Thanks much for the info. Just scanned the study design and HemoStyp is being compared to Surgicel in a non-inferiority trial in 222 patients. The start and end dates are as follows:

Estimated Study Start Date : September 6, 2018
Estimated Primary Completion Date : November 19, 2018
Estimated Study Completion Date : December 3, 2018

DR5
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UEEC News